Research ArticleExtended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: Final results from the STEPS trial
Keywords: هموگلوبین; AE; adverse event; Hb; hemoglobin; HCV; hepatitis C virus; HIV; human immunodeficiency virus; PegIFN/RBV; peginterferon-α and ribavirin; RNA; ribonucleic acid; RVR; rapid virologic response; SAE; serious adverse event; SVR; sustained virologic response;